Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-06

Clinical Trial Update: Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing morning versus bedtime aspirin administration for cardiovascular chronotherapy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Tor Biering-Sørensen | Conditions: Atherosclerosis, Cardiovascular Diseases | Phase 4 | Status: RECRUITING